Clinical Trial Imaging Market Size Worth $1.97 Billion By 2030
Clinical Trial Imaging Industry Overview The global clinical trial imaging market is expected to reach USD 1.97 billion by 2030, exhibiting a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker. Clinical Trial Imaging Market Segmentation Grand View Research has segmented the global clinical trial imaging market on the basis of service, application, end-use, and region: Based on the Service Insights, the market is segmented into clinical trial design and c...